Table 1.

Characteristics of patients with ITP

Patient no./
age,y
/sex
Duration of
ITP
Plt counts in 3 mo
before study
(× 109/L)
Previous bleeding
episodes
Splenectomy
(time after surgery)
Previous therapy*Current therapy
1/37/M 5 y 10 mo  1-14 Ecchymoses,
petechiae 
Yes (5 y 9 mo) Azathioprine, cyclophosphamide, cyclosporine, methotrexate, danazol, ascorbic acid, IVIG, vincristine, platelet transfusion, interferon α-2b, colchicine, dapsone Prednisone,
ascorbic acid  
2/61/F 9 y 10 mo  5-17 Ecchymoses,
gingival 
No Azathioprine Prednisone 
3/67/F 7 y 11-25 —  No Chinese medicine (Kamikihito) None 
4/57/M 8 y 6 mo 6-8 Ecchymoses,
petechiae 
Yes (8 y 1 mo) Azathioprine, cyclophosphamide, cyclosporine, interferon, danazol, ascorbic acid, vincristine, dapsone Prednisone,
ascorbic acid 
Patient no./
age,y
/sex
Duration of
ITP
Plt counts in 3 mo
before study
(× 109/L)
Previous bleeding
episodes
Splenectomy
(time after surgery)
Previous therapy*Current therapy
1/37/M 5 y 10 mo  1-14 Ecchymoses,
petechiae 
Yes (5 y 9 mo) Azathioprine, cyclophosphamide, cyclosporine, methotrexate, danazol, ascorbic acid, IVIG, vincristine, platelet transfusion, interferon α-2b, colchicine, dapsone Prednisone,
ascorbic acid  
2/61/F 9 y 10 mo  5-17 Ecchymoses,
gingival 
No Azathioprine Prednisone 
3/67/F 7 y 11-25 —  No Chinese medicine (Kamikihito) None 
4/57/M 8 y 6 mo 6-8 Ecchymoses,
petechiae 
Yes (8 y 1 mo) Azathioprine, cyclophosphamide, cyclosporine, interferon, danazol, ascorbic acid, vincristine, dapsone Prednisone,
ascorbic acid 

ITP indicates idiopathic thrombocytopenic purpura; Plt, platelet; and IVIG, intravenous immunoglobulin.

*

All patients had ITP refractory to initial steroid therapy.

or Create an Account

Close Modal
Close Modal